# Relaxed targeting rules help PIWI proteins silence transposons

**Authors:** Ildar Gainetdinov, Joel Vega-Badillo, Katharine Cecchini, Ayca Bagci, Cansu Colpan, Dipayan De, Shannon Bailey, Amena Arif, Pei-Hsuan Wu, Ian J. MacRae, Phillip D. Zamore

PMC · DOI: 10.1038/s41586-023-06257-4 · Nature · 2023-06-21

## TL;DR

PIWI proteins can silence transposons more effectively than AGO proteins by tolerating RNA mismatches, helping defend the genome without needing new RNA guides.

## Contribution

PIWI proteins tolerate mismatches in RNA targets, making them more effective at silencing transposons compared to AGO proteins.

## Key findings

- PIWI proteins can cleave transcripts with partial complementarity to their piRNA guides.
- PIWI slicing does not require canonical seed pairing, unlike AGO proteins.
- PIWI proteins avoid silencing host RNAs while efficiently targeting transposons.

## Abstract

In eukaryotes, small RNA guides, such as small interfering RNAs and microRNAs, direct AGO-clade Argonaute proteins to regulate gene expression and defend the genome against external threats. Only animals make a second clade of Argonaute proteins: PIWI proteins. PIWI proteins use PIWI-interacting RNAs (piRNAs) to repress complementary transposon transcripts1,2. In theory, transposons could evade silencing through target site mutations that reduce piRNA complementarity. Here we report that, unlike AGO proteins, PIWI proteins efficiently cleave transcripts that are only partially paired to their piRNA guides. Examination of target binding and cleavage by mouse and sponge PIWI proteins revealed that PIWI slicing tolerates mismatches to any target nucleotide, including those flanking the scissile phosphate. Even canonical seed pairing is dispensable for PIWI binding or cleavage, unlike plant and animal AGOs, which require uninterrupted target pairing from the seed to the nucleotides past the scissile bond3,4. PIWI proteins are therefore better equipped than AGO proteins to target newly acquired or rapidly diverging endogenous transposons without recourse to new small RNA guides. Conversely, the minimum requirements for PIWI slicing are sufficient to avoid inadvertent silencing of host RNAs. Our results demonstrate the biological advantage of PIWI over AGO proteins in defending the genome against transposons and suggest an explanation for why the piRNA pathway was retained in animal evolution.

Of the two types of Argonaute proteins produced by animals, AGO and PIWI, PIWI proteins can bind RNAs with less complementarity, enabling efficient silencing of transposons without the need to produce new RNA guides.

## Linked entities

- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, Fam72a (family with sequence similarity 72, member A) [NCBI Gene 108900] {aka 2700049P18Rik, P17}, Mbp (myelin basic protein) [NCBI Gene 17196] {aka Hmbpr, golli-mbp, jve, mld, shi}, Vwc2 (von Willebrand factor C domain containing 2) [NCBI Gene 319922] {aka A930041G11Rik, G11, PSST739, UNQ739, cradin}, Ythdc2 (YTH domain containing 2) [NCBI Gene 240255] {aka 3010002F02Rik, mYTHDC2}, Gtsf1 (gametocyte specific factor 1) [NCBI Gene 74174] {aka 1700006H03Rik, Cue110}, Serpinb9 (serine (or cysteine) peptidase inhibitor, clade B, member 9) [NCBI Gene 20723] {aka CAP-3, CAP3, PI-9, PI9, Spi6, ovalbumin}, Serpine2 (serine (or cysteine) peptidase inhibitor, clade E, member 2) [NCBI Gene 20720] {aka B230326M24Rik, PAI-1, PI-7, PI7, PN-1, Spi4}, PIWIL1 (piwi like RNA-mediated gene silencing 1) [NCBI Gene 9271] {aka CT80.1, HIWI, MIWI, PIWI}, Mirlet7a-1 (microRNA let7a-1) [NCBI Gene 387244] {aka Let-7a, Mirnlet7a, Mirnlet7a-1, let-7a-1}, Kctd7 (potassium channel tetramerisation domain containing 7) [NCBI Gene 212919] {aka 4932409E18, 9430010P06Rik}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Neb (nebulin) [NCBI Gene 17996], Piwil2 (piwi-like RNA-mediated gene silencing 2) [NCBI Gene 57746] {aka Piwil1l, mili}, Pnkp (polynucleotide kinase 3'- phosphatase) [NCBI Gene 59047] {aka 1810009G08Rik, PNK}, Bud31 (BUD31 homolog) [NCBI Gene 231889] {aka EDG-2, EDG2, G10}, PIWIL3 (piwi like RNA-mediated gene silencing 3) [NCBI Gene 440822] {aka HIWI3}, PIWIL2 (piwi like RNA-mediated gene silencing 2) [NCBI Gene 55124] {aka CT80, HILI, PIWIL1L, mili}, GTSF1 (gametocyte specific factor 1) [NCBI Gene 121355] {aka Cue110, FAM112B}, Mir34b (microRNA 34b) [NCBI Gene 723849] {aka Mirn34b, mir-34b, mmu-mir-34b}, Sycp3 (synaptonemal complex protein 3) [NCBI Gene 20962] {aka Cor1, Scp3}, Mir21a (microRNA 21a) [NCBI Gene 387140] {aka Mir21, Mirn21, mmu-mir-21, mmu-mir-21a}, AGO2 (argonaute RISC catalytic component 2) [NCBI Gene 27161] {aka CASC7, EIF2C2, LESKRES, LINC00980, PPD, Q10}, Ago2 (argonaute RISC catalytic subunit 2) [NCBI Gene 239528] {aka 1110029L17Rik, 2310051F07Rik, Eif2c2, Gerp95, Gm10365, mKIAA4215}, Piwil1 (piwi-like RNA-mediated gene silencing 1) [NCBI Gene 57749] {aka MIWI}, LILRB1 (leukocyte immunoglobulin like receptor B1) [NCBI Gene 10859] {aka CD85J, ILT-2, ILT2, LIR-1, LIR1, MIR-7}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Pnldc1 (poly(A)-specific ribonuclease (PARN)-like domain containing 1) [NCBI Gene 240023] {aka Gm313}, Mir155 (microRNA 155) [NCBI Gene 387173] {aka Mirn155, mir-155, mmu-mir-155}, Mir449a (microRNA 449a) [NCBI Gene 723868] {aka Mirn449, Mirn449a, mir-449a, mmu-mir-449}
- **Diseases:** ND (MESH:C537849)
- **Chemicals:** SDS (MESH:D012967), EDTA (MESH:D004492), CaCl2 (MESH:D002122), peptide (MESH:D010455), paraformaldehyde (MESH:C003043), oligonucleotide (MESH:D009841), potassium acetate (MESH:D019347), xylene cyanol (MESH:C048951), urea (MESH:D014508), phenol (MESH:D019800), KOH (MESH:C029943), 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (MESH:C002010), CHAPS (MESH:C028213), PEG-8000 (MESH:C000595216), glycerol (MESH:D005990), M2 (MESH:C034584), DAPI (MESH:C007293), ZnSO4 (MESH:D019287), t1S (MESH:C103828), dUTP (MESH:C027078), Purine (MESH:C030985), isoamyl alcohol (MESH:C029683), TCEP (MESH:C080938), DTT (MESH:D004229), phosphate (MESH:D010710), imidazole (MESH:C029899), E-64 (MESH:C024974), nylon (MESH:D009757), chloroform (MESH:D002725), Hoechst 33342 (MESH:C017807), Propidium iodide (MESH:D011419), Triton X-100 (MESH:D017830), Alexa Fluor 488 (MESH:C000711379), IPTG (MESH:D007544), water (MESH:D014867), ATP (MESH:D000255), PBS (MESH:D007854), NaCl (MESH:D012965), nitrogen (MESH:D009584), Cytiva (-), formamide (MESH:C031066), agarose (MESH:D012685), nickel (MESH:D009532), sucrose (MESH:D013395), bromophenol blue (MESH:D001978), EGTA (MESH:D004533), calcium (MESH:D002118), trypan blue (MESH:D014343), CO2 (MESH:D002245), ethanol (MESH:D000431), MgCl2 (MESH:D015636), HEPES (MESH:D006531), HCl (MESH:D006851), magnesium acetate (MESH:C000656591), polyacrylamide (MESH:C016679), NaOH (MESH:D012972)
- **Species:** Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Ephydatia fluviatilis (species) [taxon 31330], Ephydatia muelleri (Mueller's freshwater sponge, species) [taxon 6052], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** K in 100, K227Q, C with 60, C2527H, M2080S, C in 5, M0437M, M100P, M110P
- **Cell lines:** Rosetta-Gami 2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), S20 — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_VU14), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), BL21(DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM), Sf9 — Spodoptera frugiperda (Fall armyworm), Spontaneously immortalized cell line (CVCL_0549)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10338343/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10338343/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC10338343/full.md

---
Source: https://tomesphere.com/paper/PMC10338343